BioCentury
ARTICLE | Company News

Vernalis, Taisho Pharmaceutical Holdings deal

May 4, 2015 7:00 AM UTC

Under an exclusive deal, the companies will develop antibiotics against an undisclosed target using Vernalis’ fragment and structure-based drug discovery platform. Vernalis declined to provide further...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article